ARS Pharmaceuticals, Inc (SPRY) is a biotechnology company listed on NASDAQ.
Latest reported SPRY revenue for 2026-06-30 was $56.3M. Net income was -$123.0M. SPRY currently screens at market cap $983.1M.
Use this SPRY page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the SPRY quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the SPRY SEC filings page. Lician reads the product cache first so this HTML stays unique to ARS Pharmaceuticals, Inc even when a live quote feed is slow.
Latest cached year on this hub. Full SPRY income, balance, and cash tables.